ASPEN PHARMACR Cash Flow - Quarterly (OTCMKTS:APNHY)

Add to My Stocks
$11.4 $0.22 (1.97%) APNHY stock closing price Oct 15, 2018 (Closing)

The cash flow statement is one of the reports a publicly traded company like ASPEN PHARMACR needs to disclose. The profit-loss statement shows ASPEN PHARMACR profits, the balance sheet shows ASPEN PHARMACR debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. ASPEN PHARMACR had cash and cash equivalents of $478.86M at beginning of the quarter and $521.85M at quarter end of 2018 Q2. ASPEN PHARMACR cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. ASPEN PHARMACR saw a outflow of $-595.35M from investing activities till 2018 Q2.

View and download details of ASPEN PHARMACR cash flows for latest & last 40 quarters
show more
Fiscal year is Jul - Jun2018 Q22017 Q42017 Q22016 Q4
Net Income Cash Flow
448.35M610.05M394.9M624.6M
Depreciation Depletion Amortization Cash-Flow-95.55M-83.28M
Net Increase (Decrease) in Assets Liabilities-110.25M-66.14M-50.26M-235.96M
Cash From (used in) Discontinued Operations----
Other Adjustments Net-117.6M-161.7M-114.88M-249.84M
Net Cash from (used by) Operating Activities
220.5M477.75M229.76M222.08M
Increase (Decrease) in Prop Plant And Equipment-58.8M-110.25M-50.26M-117.98M
Acquisition Disposition of Subsidiaires--698.25M-430.8M-48.58M
Increase (Decrease) in Investments----
Other Cash Inflow (Outflow) from Investment Activities-536.55M-51.45M-78.98M242.9M
Net Cash from (used by) Investment Activities
-595.35M-859.95M-560.04M76.34M
Issuance (Purchase) of Equity Shares----6.94M
Issuance (Repayment) of Debt Securities470.4M455.7M430.8M-138.8M
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions-95.55M-88.2M-78.98M-69.4M
Other Cash from (used by) Financing Activities----
Net Cash from (used by) Financing Activities
374.85M367.5M351.82M-215.14M
Effect of Exchange Rate Changes on Cash-7.35M-36.75M-50.26M-13.88M
Net Change in Cash & Cash Equivalents
-7.35M-51.45M-28.72M69.4M
Cash & Equivalents at Beginning of Year478.86M---
Cash & Equivalents at Year End521.85M529.2M538.5M548.26M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The ASPEN PHARMACR stock price history and ASPEN PHARMACR stock comparison chart inevitably reflect its cash flow situation.

  • ASPEN PHARMACR has cash of $521.85M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the ASPEN PHARMACR stock price.
  • ASPEN PHARMACR increased its cash from operating activities to $220.5M till 2018 Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-595.35M for APNHY till last quarter 2018 Q2 report.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. ASPEN PHARMACR earned $374.85M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For ASPEN PHARMACR Cash Flow